Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities Participating in the Pharmacy Partnership for Long-Term Care Program - United States, December 2020-January 2021.
Aged
COVID-19
/ epidemiology
COVID-19 Vaccines
/ administration & dosage
Centers for Disease Control and Prevention, U.S.
Humans
Long-Term Care
Pharmacy
/ organization & administration
Program Evaluation
Public-Private Sector Partnerships
Skilled Nursing Facilities
/ organization & administration
United States
/ epidemiology
Vaccination Coverage
/ statistics & numerical data
Journal
MMWR. Morbidity and mortality weekly report
ISSN: 1545-861X
Titre abrégé: MMWR Morb Mortal Wkly Rep
Pays: United States
ID NLM: 7802429
Informations de publication
Date de publication:
05 Feb 2021
05 Feb 2021
Historique:
entrez:
4
2
2021
pubmed:
5
2
2021
medline:
7
2
2021
Statut:
epublish
Résumé
Residents and staff members of long-term care facilities (LTCFs), because they live and work in congregate settings, are at increased risk for infection with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19) (1,2). In particular, skilled nursing facilities (SNFs), LTCFs that provide skilled nursing care and rehabilitation services for persons with complex medical needs, have been documented settings of COVID-19 outbreaks (3). In addition, residents of LTCFs might be at increased risk for severe outcomes because of their advanced age or the presence of underlying chronic medical conditions (4). As a result, the Advisory Committee on Immunization Practices has recommended that residents and staff members of LTCFs be offered vaccination in the initial COVID-19 vaccine allocation phase (Phase 1a) in the United States (5). In December 2020, CDC launched the Pharmacy Partnership for Long-Term Care Program* to facilitate on-site vaccination of residents and staff members at enrolled LTCFs. To evaluate early receipt of vaccine during the first month of the program, the number of eligible residents and staff members in enrolled SNFs was estimated using resident census data from the National Healthcare Safety Network (NHSN
Identifiants
pubmed: 33539332
doi: 10.15585/mmwr.mm7005e2
pmc: PMC7861479
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
178-182Déclaration de conflit d'intérêts
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. David Gifford reports that his wife serves as the commissioner of public health in Connecticut, a jurisdiction involved in the Pharmacy Partnership for Long-Term Care Program partnership. Aaron Jaffe reports that his employer, Palantir Technologies, is in a paid engagement with the U.S. Department of Health and Human Services for providing software and configuration services. No other potential conflicts of interest were disclosed.
Références
MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1857-1859
pubmed: 33301429
J Am Geriatr Soc. 2020 Dec 28;:
pubmed: 33370448
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
J Am Med Dir Assoc. 2020 Oct;21(10):1390-1391
pubmed: 32893137
JAMA. 2020 Nov 17;324(19):1928-1930
pubmed: 33112395
MMWR Morb Mortal Wkly Rep. 2018 Sep 28;67(38):1050-1054
pubmed: 30260944
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):52-55
pubmed: 33444301
Am J Infect Control. 2015 Feb;43(2):100-6
pubmed: 25637113